New England Journal of Medicine

FDA will review safety of testosterone therapy

(HealthDay)—Spurred by a recent report that popular testosterone treatments might raise men's heart risk, the U.S. Food and Drug Administration says it now plans a review of the therapies' safety.

Feb 03, 2014
popularity not rated yet | comments 0

Framework established to promote safety of care

(HealthDay)—A framework has been established to advance clinical learning environments that promote change in the quality and safety of care, according to a perspective piece published online Jan. 27 in ...

Jan 29, 2014
popularity not rated yet | comments 0

More illness from synthetic marijuana likely

The U.S. should prepare for more outbreaks of illness and possible deaths from designer drugs including synthetic marijuana, according to the new research from the University of Colorado School of Medicine.

Jan 22, 2014
popularity not rated yet | comments 0